Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. CORTIMENT (budésonide)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

CORTIMENT (budésonide)

Medicine - Posted on Nov 18 2019
Active substance (DCI)
  • budésonide
history (4)
  • 10/6/21

    CORTIMENT 9 mg (budésonide) (traitement d’induction d’une rémission chez des patients souffrant d’une colite microscopique active)

    Key points Unfavourable opinion for reimbursement in the induction of remission in patients with active microscopic colitis ...
    icône flèche
  • 10/23/19

    CORTIMENT (budésonide)

    L’essentiel Avis favorable au maintien du remboursement dans le traitement d’induction d’une rémission chez les patients adu...
    CAV :
    54321
    icône flèche
  • 11/7/18

    CORTIMENT (budésonide)

    CORTIMENT (budésonide)
    icône flèche
  • 1/25/17

    CORTIMENT (budesonide), corticosteroid for local use

    No clinical benefit demonstrated in the treatment strategy for ulcerative colitis (UC). CORTIMENT has Marketing Authorisatio...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • A07EA06
Manufacturer
FERRING SAS
Presentation

CORTIMENT 9 mg, comprimé à libération prolongée (code CIS : 64380476)
plaquette(s) polyamide aluminium PVC de 10 comprimé(s) - Code CIP : 34009 300 557 1 7
plaquette(s) polyamide aluminium PVC de 30 comprimé(s) - Code CIP : 34009 300 557 3 1

All our publications
    Autoimmune diseases Drug therapy Esophageal and gastrointestinal diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
UTRunQRxKybQjx6J